Gastrointestinal symptoms are the most common with retatrutide, as with other GLP-1 drugs
On July 23 at 12 PM ET, Managed Healthcare Executive is hosting a free webinar, The Great 340B Debate, with Peter Wehrwein moderating and panelists Shawn Gremminger from National Alliance of Healthcare Purchaser Coalitions and Tom Kraus from ASHP
If you reconstitute a 30 mg vial with sterile water and plan to draw doses over several weeks, you are creating a contamination risk that increases with every injection
Chronic kidney disease and risk management: standards of Care in Diabetes-2023
However, GLP-1 receptors exist throughout the cardiovascular system, including in heart tissue and blood vessel walls
Keeping a close eye on how the patient is doing is key to adjusting the treatment as needed